![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
- Anderson L.J. and Hurwitz E.S. (1988) Human Parvovirus B19 and pregnancy. Clinical Perinatology, 15,273-286.
- Carrington D., Gilmore D.H., Whittle M.J., Aitken D., Gibson A.A., Patrick W.J. and Brown T. (1984) Maternal serum alpha fetoprotein-a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet, 1,433-435.
- Cohen B. (1995) Parvovirus B19: an expanding spectrum of disease. British Medical Journal, 311,1549-1552.
- Gratacos E., Torres P.J., Vidai J., Antolin E., Costa J., Jimenezda-Anta M.T., Cararach V., Alonso P.L. and Fortuny A. (1995). The incidence of human Parvovirus B19 infection during pregnancy and its impact on perinatal outcome. Journal of Infectious Diseases, 171,1360-1363.
- Kinney J.S., Anderson L.J., Farrar J., Strikes R.A., Kumar M.L., Kliegman R.M., Sever J.L., Hurwitz E.S. and Sikes R.K. ( 1988) Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. Journal of Infectious Diseases, 157, 663-667.
- Public Health Laboratory Service Working Party on Fifth Disease (1990) Prospective study of human parvovirus (B19) infection in pregnancy. British Medical Journal, 300,1166-1170.
Journal of Obstetrics and Gynaecology
Volume 21, 2001 - Issue 5